Rithm closes DRA joint venture at 1301 Avenue of the Americas

Rithm Capital has closed a joint venture with a fund managed by DRA Advisors covering 1301 Avenue of the Americas, one of the flagship assets in Elecor Properties' New York City office portfolio, which Rithm bought in December 2025. Rithm keeps majority ownership through Elecor and continues to operate the building on the venture's behalf, though the announcement does not disclose terms or the size of the DRA fund's stake.

IREI reported the closing. The announcement describes a structure in which a sponsor that bought the entire portfolio outright, spent on the buildings themselves, and is now bringing in a partner at one asset keeps control, the leasing effort and the operating mandate. The venture has closed rather than merely been agreed, so the equity is in place today; the announcement simply attaches no price to it.

For Rithm, the asset management role is the part that matters. Elecor operates the building on behalf of the joint venture, carrying a management role over a partner's share as well as its own, and it stays close to the leasing and capital decisions that will determine whether the December 2025 entry looks smart. A minority partner reduces the equity tied up in one New York tower without giving up the operating role or the relationship, though the announcement does not say whether that is why Rithm did this.

"We are excited to begin our partnership with DRA, which reflects our shared conviction in the long-term value of high-quality office assets," Rithm chief executive Michael Nierenberg said in the announcement. The same statement credits leasing activity across New York's leading office assets with reinforcing demand for best-in-class space—a view of the market offered by the sponsor of the building in question.

The backdrop is last December's bet, when Rithm acquired Elecor and its portfolio of high-quality class A office buildings in New York and San Francisco, a purchase it framed at the time as capitalizing on what it called a generational opportunity in the office market. Since then the company has invested in capital improvements across the portfolio and scaled the asset management platform to support it, and the money has gone to a lobby and two amenity floors at 1633 Broadway, a wager that a renovated building can move a tenant roster up-market. The pattern is spending on the buildings themselves rather than waiting for the rent roll to do the work.

Leasing has cooperated on at least one floorplate. KeyBank signed a 15-year renewal and expansion at Elecor Tower in August, according to our reporting, adding 15,292 square feet and turning a Plaza District presence into a New York headquarters. A bank committing for fifteen years is the sort of tenancy a partner can underwrite from the outside, and it likely explains why a manager of DRA's size would want a minority seat in a single building instead of waiting for a piece of the whole platform.

DRA is not a small counterparty. It runs $14.4 billion in regulatory assets with 99 employees as of late September, and it has been raising institutional money: the Montana Board of Investments committed $50 million to one of its value-add funds in September, keeping the pension near its 12% real estate target. The position it takes here has a different shape—minority, non-operating, one asset—and the announcement does not say whether the capital came from a fund, a separate account or a co-investment sleeve.

The deal yields no comparable. A week before this announcement, a Ballston building cleared at $299 a foot on a $56.25 million price and a rent roll next to federal tenants, with the buyer left unnamed—a print, however narrow. A recapitalization with undisclosed terms establishes that a partner wanted in and roughly where a sponsor's conviction sits, but it says nothing about the clearing level for a New York tower.

That fits the maturity-wall argument: office's capital problem has been resolved more by structure than by repricing, with extensions, preferred equity and rescue capital doing the work, and the collateral that clears is the collateral whose income you can see. A bank on a fifteen-year lease inside a flagship asset fits that description, and the arrival of patient equity is consistent with it. Reading the venture as evidence about the refinancing wall itself would be a stretch; the announcement says nothing about a loan, a maturity or the existing capital stack at 1301, and it frames the transaction as an ownership structure, not a workout.

The company says the strength of the assets and the operating company has drawn growing interest from institutional investors seeking to partner on high-quality real estate, and that the DRA relationship lets it keep growing the asset management platform while remaining involved in the building's long-term success. The San Francisco buildings acquired in the same December 2025 transaction, and the New York assets that sit alongside 1301, are the likeliest next candidates. The announcement does not say how many assets Rithm intends to bring partners into, or whether DRA's interest reaches past this one.